Traditional Chinese medicine, Danlou tablets alleviate adverse left ventricular remodeling after myocardial infarction: results of a double-blind, randomized, placebo-controlled, pilot study

BACKGROUND: Danlou tablets, a patented Chinese Medicine, have been long approved for the treatment of ischemic heart disease in China. While numerous empirical observations suggested Danlou tablets could decrease frequency and duration of angina pectoris attacks, evidence supporting its efficacy on...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Complement Altern Med
Main Authors: Mao, Shuai, Wang, Lei, Ouyang, Wenwei, Zhou, Yuanshen, Qi, Jianyong, Guo, Liheng, Zhang, Minzhou, Hinek, Aleksander
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5101662/
https://ncbi.nlm.nih.gov/pubmed/27825334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-016-1406-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki